Canada Life
VKTX icon

Canada Life’s Viking Therapeutics VKTX Stock Holding History

Canada Life’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$530K Buy
16,247
+1,945
+14% +$62.5K ﹤0.01% 1495
2025
Q4 		$503K Buy
14,302
+2,682
+23% +$95K ﹤0.01% 1503
2025
Q3 		$300K Hold
11,620
– – ﹤0.01% 1661
2025
Q2 		$308K Sell
11,620
-12,162
-51% -$320K ﹤0.01% 1671
2025
Q1 		$575K Sell
23,782
-59,797
-72% -$1.89M ﹤0.01% 1578
2024
Q4 		$3.36M Sell
83,579
-696
-0.8% -$39.7K 0.01% 1030
2024
Q3 		$5.34M Buy
84,275
+1,859
+2% +$109K 0.01% 829
2024
Q2 		$4.36M Buy
82,416
+5,780
+8% +$379K 0.01% 895
2024
Q1 		$6.29M Buy
76,636
+67,877
+775% +$3.02M 0.01% 708
2023
Q4 		$162K Hold
8,759
– – ﹤0.01% 1870
2023
Q3 		$97K Buy
8,759
+4,233
+94% +$60.5K ﹤0.01% 1968
2023
Q2 		$74K Buy
4,526
+775
+21% +$16.2K ﹤0.01% 1959
2023
Q1 		$63K Buy
+3,751
New +$38.7K ﹤0.01% 2035
2022
Q2 		– Sell
-3,830
Closed -$12K – 2465
2022
Q1 		$12K Hold
3,830
– – ﹤0.01% 2419
2021
Q4 		$18K Hold
3,830
– – ﹤0.01% 2398
2021
Q3 		$24K Hold
3,830
– – ﹤0.01% 2396
2021
Q2 		$23K Hold
3,830
– – ﹤0.01% 2461
2021
Q1 		$24K Hold
3,830
– – ﹤0.01% 2482
2020
Q4 		$22K Hold
3,830
– – ﹤0.01% 2523
2020
Q3 		$22K Hold
3,830
– – ﹤0.01% 2423
2020
Q2 		$27K Hold
3,830
– – ﹤0.01% 2430
2020
Q1 		$18K Hold
3,830
– – ﹤0.01% 2394
2019
Q4 		$30K Buy
+3,830
New +$27.9K ﹤0.01% 2412
2019
Q3 		– Sell
-7,219
Closed -$60K – 2247
2019
Q2 		$60K Hold
7,219
– – ﹤0.01% 2393
2019
Q1 		$71K Hold
7,219
– – ﹤0.01% 2172
2018
Q4 		$53K Buy
+7,219
New +$86.3K ﹤0.01% 2350

Other funds holding VKTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Canada Life's VKTX Position: Q1 2026 in Review

Canada Life increased its Viking Therapeutics (VKTX) stake by 14% in Q1 2026, buying an estimated $62.5K and bringing the position to 16,247 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #1495.

Canada Life first reported a position in VKTX in Q4 2018 and has held it in 26 quarters since. The position peaked at $6.29M in Q1 2024. 410 funds tracked by Wall St. Rank hold VKTX as of Q1 2026.

  • Canada Life held 16,247 shares of Viking Therapeutics worth $530K as of Q1 2026.
  • Canada Life bought 1,945 Viking Therapeutics shares in Q1 2026, an estimated $62.5K.
  • Viking Therapeutics made up ﹤0.01% of Canada Life's portfolio in Q1 2026, its #1495 holding.
  • Canada Life first reported a position in Viking Therapeutics in Q4 2018 and has held it in 26 quarters since.
  • Canada Life's Viking Therapeutics position peaked at $6.29M in Q1 2024.
  • 410 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2026.

Based on Canada Life's 13F filing for Q1 2026, filed 14 May 2026.